liposomal tamoxifen (BTG)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameliposomal tamoxifen (BTG)
Drug Alias Nameliposomal tamoxifen (Max-Delbrueck/BTG)tamoxifen
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitorsEstrogen receptors modulators
TargetsEstrogen receptorsProtein kinase C
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMax Delbruck Centrum Fur Molekulare Medizin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBtg Limited
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A